会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 91. 发明授权
    • Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution
    • 可溶性,可降解的聚(乙二醇)衍生物,用于将结合分子可控地释放到溶液中
    • US06864350B2
    • 2005-03-08
    • US10318322
    • 2002-12-12
    • J. Milton Harris
    • J. Milton Harris
    • A61K47/48C08G65/333A61K31/74A61K31/765C08G73/10
    • C08G65/33396A61K47/60C08G65/33317
    • PEG and related polymer derivatives having weak, hydrolytically unstable linkages near the reactive end of the polymer are provided for conjugation to drugs, including proteins, enzymes, small molecules, and others. These derivatives provide a sufficient circulation period for a drug-PEG conjugate and then for hydrolytic breakdown of the conjugate and release of the bound molecule. In some cases, drugs that previously had reduced activity when permanently coupled to PEG can have therapeutically suitable activity when coupled to a degradable PEG in accordance with the invention. The PEG of the invention can be used to impart water solubility, size, slow rate of kidney clearance, and reduced immunogenicity to the conjugate. Controlled hydrolytic release of the bound molecule in the aqueous environment can then enhance the drug delivery system.
    • 提供在聚合物的反应性末端附近具有弱的水解不稳定键的PEG和相关的聚合物衍生物用于与药物(包括蛋白质,酶,小分子等)共轭。 这些衍生物为药物-PEG缀合物提供足够的循环周期,然后用于结合物的水解分解和结合分子的释放。 在一些情况下,当与PEG偶联时,先前具有减少的活性的药物在与根据本发明的可降解的PEG偶联时可具有治疗上合适的活性。 本发明的PEG可用于赋予水溶性,大小,缓慢的肾清除率,降低对缀合物的免疫原性。 在水环境中控制的结合分子的水解释放可以增强药物递送系统。
    • 93. 发明授权
    • Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
    • 可溶性,可降解的聚(乙二醇)衍生物,用于将结合分子可控地释放到溶液中
    • US06214966B1
    • 2001-04-10
    • US08937846
    • 1997-09-25
    • J. Milton Harris
    • J. Milton Harris
    • A61K31765
    • C08G65/33396A61K47/60C08G65/33317
    • PEG and related polymer derivatives having weak, hydrolytically unstable linkages near the reactive end of the polymer are provided for conjugation to drugs, including proteins, enzymes, small molecules, and others. These derivatives provide a sufficient circulation period for a drug-PEG conjugate and then for hydrolytic breakdown of the conjugate and release of the bound molecule. In some cases, drugs that previously had reduced activity when permanently coupled to PEG can have therapeutically suitable activity when coupled to a degradable PEG in accordance with the invention. The PEG of the invention can be used to impart water solubility, size, slow rate of kidney clearance, and reduced immunogenicity to the conjugate. Controlled hydrolytic release of the bound molecule in the aqueous environment can then enhance the drug delivery system.
    • 提供在聚合物的反应性末端附近具有弱的水解不稳定键的PEG和相关的聚合物衍生物用于与药物(包括蛋白质,酶,小分子等)共轭。 这些衍生物为药物-PEG缀合物提供足够的循环周期,然后用于结合物的水解分解和结合分子的释放。 在一些情况下,当与PEG偶联时,先前具有减少的活性的药物在与根据本发明的可降解的PEG偶联时可具有治疗上合适的活性。 本发明的PEG可用于赋予水溶性,大小,缓慢的肾清除率,降低对缀合物的免疫原性。 在水环境中控制的结合分子的水解释放可以增强药物递送系统。
    • 94. 发明授权
    • Multiarmed, monofunctional, polymer for coupling to molecules and
surfaces
    • 用于偶联到分子和表面的多臂单功能聚合物
    • US5932462A
    • 1999-08-03
    • US443383
    • 1995-05-17
    • J. Milton HarrisFrancesco Maria VeronesePaolo CalicetiOddone Schiavon
    • J. Milton HarrisFrancesco Maria VeronesePaolo CalicetiOddone Schiavon
    • A61K47/48C08G65/329C12N9/96A01N63/00C07K17/00C12N11/06
    • C08G65/48A61K47/48215C08G65/329C12N9/96Y10S530/815Y10S530/816
    • Multi-armed, monofunctional, and hydrolytically stable polymers are described having the structure ##STR1## wherein Z is a moiety that can be activated for attachment to biologically active molecules such as proteins and wherein P and Q represent linkage fragments that join polymer arms poly.sub.a and poly.sub.b, respectively, to central carbon atom, C, by hydrolytically stable linkages in the absence of aromatic rings and ester groups in the linkage fragments. R typically is hydrogen or methyl, but can be a linkage fragment that includes another polymer arm. A specific example is an mPEG disubstituted lysine having the structure ##STR2## where mPEG.sub.a and mPEG.sub.b have the structure CH.sub.3 O--(CH.sub.2 CH.sub.2 O).sub.n CH.sub.2 CH.sub.2 -- wherein n may be the same or different for mPEG.sub.a and mPEG.sub.b and can be from 1 to about 1,150 to provide molecular weights of from about 100 to 100,000. The mPEG disubstituted lysine can be purified from a reaction mixture by chromatography in water, including gel filtration chromatography and ion exchange chromatography because the carboxyl group is ionizable. Impurities are removed, including unreacted mPEG and mPEG monosubstituted lysine, to provide the polymer in pure form. Ion exchange chromatography permits fractionation of a greater amount of polymer per run.
    • 描述了具有以下结构的多臂,单功能和水解稳定的聚合物,其中Z是可被激活以附着于生物活性分子如蛋白质的部分,并且其中P和Q分别表示分别连接聚合物臂polya和polyb的连接片段 ,通过在不存在芳环和通过连接片段中的酯基的水解稳定键连接到中心碳原子。 R通常是氢或甲基,但可以是包含另一聚合物臂的连接片段。 具体实例是具有mPEGa和mPEGb具有CH 3 O-(CH 2 CH 2 O)n CH 2 CH 2结构的结构的mPEG二取代的赖氨酸,其中n可以相同或不同于mPEGa和mPEGb,并且可以为1至约1,150,以提供 从约100到100,000。 可以通过色谱法在水中从反应混合物中纯化mPEG二取代的赖氨酸,包括凝胶过滤色谱和离子交换色谱法,因为羧基是可离子化的。 除去杂质,包括未反应的mPEG和mPEG单取代的赖氨酸,以提供纯的形式的聚合物。 离子交换色谱法允许每次运行更大量的聚合物分级。